Overview of Skin Cancers for General Practitioners

Tarek Haykal

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

Updates on Extramammary Paget Disease (EMPD)

Keith Duffy

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

Checkpoint Inhibitors and Rheumatic Disease

NYU Langone

A. Bass

Update in Treatment of Advanced Non-Melanoma Skin Cancers

Cleveland Clinic Dermatology & Plastic Surgery Institute

A. Vij

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

AAD 2024

V. Sondak

Points to Consider When Managing Inflammatory Arthritis with Cancer

RheumNow

J. Cush

Summer AAD 2024 Insights: Advances in Merkel Cell Carcinoma- Using C…

AAD 2024

L. Zaba

What to Do When Patch Testing is Negative?

American Contact Dermatitis Society (ACDS)

M. Montanez-Wiscovich

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

AAD 2024 Insights: Prevention and Active Surveillance of Keratinocyt…

Brigham and Women's Hospital Department of Dermatology

R. Hartman

Safety and Monitoring Considerations in Systematic Therapy

Masterclasses in Dermatology

J. Cohen

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

Increasing Melanoma Incidence with Unchanged Mortality, 1999 - 2019

Jesper Bo Nielsen

AAD 2024 Insights: Management of Locally Advanced Basal Cell Carcino…

AAD 2024

V. Patel

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

AAD 2024 Insights: Digging Deeper - Challenging Oncodermatoses

AAD 2024

S. Deverapalli